AN
58
14
PWR
76
2
FOXA
34
-3
GS
78
2
ROST
52
2
MET
45
5
CF
27
-12
ABT
50
3
AMG
38
2
NTAP
65
4
PX
15
2
GOOGL
78
12
MTCH
50
2
WHR
36
-10
PSX
47
5
CINF
41
-9
T
41
2
AVB
62
-2
ROK
46
3
PYPL
52
5
AN
58
14
PWR
76
2
FOXA
34
-3
GS
78
2
ROST
52
2
MET
45
5
CF
27
-12
ABT
50
3
AMG
38
2
NTAP
65
4
PX
15
2
GOOGL
78
12
MTCH
50
2
WHR
36
-10
PSX
47
5
CINF
41
-9
T
41
2
AVB
62
-2
ROK
46
3
PYPL
52
5
Financhill
Back

Biogen Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Sell
45

BIIB
Biogen

Last Price:
208.98
Seasonality Move:
7.8%

7 Day Trial

ALL ACCESS PASS

$ 7

The little-known AI stock you need to read about now...

Get the name - FREE.

Biogen Price Quote

$208.98
+0.08 (+3.22%)
(Updated: April 27, 2024 at 4:57 AM ET)

Biogen Key Stats

Sell
45
Biogen (BIIB) is a Sell
Day range:
$199.10 - $210.83
52-week range:
$189.44 - $319.76
Dividend yield:
0%
P/E ratio:
26.21
P/S ratio:
3.15
P/B ratio:
2%
Volume:
1.9M
Avg. volume:
1.3M
1-year change:
-27.48%
Market cap:
$30.4B
Revenue:
$9.8B
EPS:
$8.01

How Much Does Biogen Make?

  • How Much Are Biogen's Sales Annually?
    BIIB Revenues are $9.8B
  • How Much Profit Does Biogen's Make A Year?
    BIIB net income is $1.2B

Is Biogen Growing As A Company?

  • What Is Biogen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Biogen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.01%

Biogen Stock Price Performance

  • Did Biogen Stock Go Up Last Month?
    Biogen share price went down by -1.47% last month
  • Did BIIB's Share Price Rise Over The Last Year?
    BIIB share price fell by -27.48% over the past 1 year

What Is Biogen 52-Week High & Low?

  • What Is Biogen’s 52-Week High Share Price?
    Biogen has traded as high as $319.76 over the past 52 weeks
  • What Is Biogen’s 52-Week Low Share Price?
    Biogen has traded as low as $189.44 over the past 52 weeks

Biogen Price To Free Cash Flow

  • Is Biogen Stock Overvalued?
    Biogen is trading at a price to free cash flow ratio of 23.67
  • Is Biogen Stock Undervalued?
    Biogen EV to Free Cash Flow ratio is 27.94
  • What Is Biogen’s Price Earnings Growth Ratio?
    BIIB PEG ratio is 0.00
  • Is Biogen Trading At A Premium To Earnings?
    Biogen EV to EBIT ratio is 22.75

Is It Risky To Buy Biogen?

  • How Much Debt Does Biogen Have?
    Total long term debt quarterly is $6.5B
  • How Much Cash Does Biogen Have?
    Cash and short term investments quarterly total is $1.1B
  • What Is Biogen’s Book Value Per Share?
    Book value per share is 105.06

Is Biogen Cash Flow Positive?

  • What Is BIIB Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.6B
  • What Is Biogen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$246.9M
  • What Is Biogen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.2B

Biogen Return On Invested Capital

  • Is Management Doing A Good Job?
    BIIB return on invested capital is 5.5%
  • What Is Biogen Return On Assets?
    ROA measures how assets are converting to revenues and is 4.44%
  • What Is BIIB Return On Equity?
    ROE is a measure of profitability and is 8.02%

Biogen Earnings Date & Stock Price

  • What Is Biogen's Stock Price Today?
    A single share of BIIB can be purchased today for 208.90
  • What Is Biogen’s Stock Symbol?
    Biogen trades on the S&P500 under the ticker symbol: BIIB
  • When Is Biogen’s Next Earnings Date?
    The next quarterly earnings date for Biogen is scheduled on July 25, 2024
  • When Is BIIB's next ex-dividend date?
    Biogen's next ex-dividend date is June 18, 2020
  • How To Buy Biogen Stock?
    You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biogen Competitors

  • Who Are Biogen's Competitors?
    Below is a list of companies who compete with Biogen or are related in some way:
    • AbbVie Inc (ABBV)
    • Bristol-Myers Squibb Co (BMY)
    • Gilead Sciences Inc (GILD)
    • Eli Lilly and Co (LLY)
    • Sage Therapeutics Inc (SAGE)

Biogen Dividend Yield

Data Unavailable

Biogen Analyst Estimates

YoY Growth Past Surprise
EPS: 1.12% 0%
Revenue: -7% 0%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 285.87
Upside from Last Price: 36.84%

Major Shareholders

  • How many BIIB shares are owned by institutional investors?
    190.3M BIIB shares are owned by institutional investors
  • How many BIIB shares are owned by insiders?
    2.2M BIIB shares are owned by insiders